Department of Microbiology, Biochemistry, and Immunology Seminar Series
Through educational seminar series, the Department of Microbiology, Biochemistry, and Immunology provides students, faculty, and staff opportunities to engage with nationally and internationally-renowned researchers from both MSM, other institutions of higher learning, and federal government agencies. Join us to hear approaches for applying rigorous research methodologies aimed to improve our scientific understanding of today's most complex problems in animal and human health.
Continue to check back for information on upcoming seminars.
Past Seminars
2019
July
- July 29, 2019: “Translation in Higher Dimensions,” presented by Michael G. Kurilla, M.D., Ph.D., Director, Division of Clinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health.
April
- April 26, 2019: “Strong Medicine, Characterization of a Traditional African Treatment for HIV/AIDS,” presented by Michael D. Powell, Ph.D. Professor, Department of Microbiology, Biochemistry, and Immunology, MSM.
2018
December
- December 14, 2018: "Immune Mechanisms at the Maternal Prevent Vertical Transmission of Viruses to the Fetus," presented by Erica L. Johnson, Ph.D., Pediatric Infectious Diseases Scientists and Instructor of Pediatrics, Division of Infectious Diseases, Emory University.
November
- November 14, 2018: "TRPM7 Ion Channels as Drug Targets in Glioma," presented by Mingli Liu, MD. PhD, Instructor, Microbiology, Biochemistry & Immunology Morehouse School of Medicine.
September
- September 26, 2018: "The Triple Threat: Chlamydia, Gonorrhea, and the Innate Immune
Response,” presented by Toni Darville, MD, Professor, Department of Microbiology and
Immunology, Division Chief of Pediatric Infectious Disease, Vice Chair for Research
at UNC.
- September 14, 2018: "Human Microbiomes and the link to Neurologic Disorders," presented by Bruce Lavin, MD, MPH, FACP, FCCP, Vice President, Head of Medical Affairs and Head of External Engagement and Policy Development, UCB Pharmaceuticals Inc.